Fact CheckerSign in

NCT04848909Active, not recruiting

Stereotactic Body Radiotherapy (SBRT) Post Prostatectomy

Post-Prostatectomy Linac-Based Ultrahypofractionated Radiotherapy for Patients With Localized Prostate Cancer: A Treatment Feasibility and Outcomes Multicenter Study

Source: ClinicalTrials.gov · Last updated 15 May 2025

Brief summary (registry, in English)

This phase I study will assess the toxicity profile and efficacy of SBRT (Stereotactic body radiotherapy) in patients with localized prostate cancer who are considered candidates for post-prostatectomy radiation.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
30 (estimated)
First submitted
12 Apr 2021
Start date
3 Jun 2021
Primary completion date
31 Dec 2034
Lead sponsor
Sunnybrook Health Sciences Centre
NCT number
NCT04848909

What you commit to

  • Study type: Interventional
  • Planned participants: 30
  • From 3 Jun 2021 to the primary completion date, 31 Dec 2034
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior pelvic radiotherapy

Other illness

  • Gross residual disease (per conventional imaging, i.e. CT and/or MRI)
  • Contraindications to radical pelvic radiotherapy (e.g. connective tissue disease or inflammatory bowel disease)

Other

  • Histological or radiological node +ve (N1) or distant metastases (M1)

Who the study is looking for

  • Histologically confirmed diagnosis of adenocarcinoma of the prostate status post radical prostatectomy
  • Completed written informed consent
  • Able and willing to complete EPIC, PORPUS, and EQ-5D questionnaires
  • A detectable PSA ≤ 2.0 ng/ml
  • Two consecutive rises in PSA and final PSA \> 0.1 ng/ml OR three or more consecutive rises in PSA

Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Sunnybrook Odette Cancer Centre
Coordinator of this site? Confirm its status
TorontoCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.